Shenzhen Weiguang Biological Products Co (SZSE:002880) 5-Year EBITDA Growth Rate : 0.60% (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Shenzhen Weiguang Biological Products Co 5-Year EBITDA Growth Rate?

Shenzhen Weiguang Biological Products Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.26.

During the past 12 months, Shenzhen Weiguang Biological Products Co's average EBITDA Per Share Growth Rate was 59.30% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -2.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 0.60% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 2.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 12 years, the highest 3-Year average EBITDA Per Share Growth Rate of Shenzhen Weiguang Biological Products Co was 27.20% per year. The lowest was -17.00% per year. And the median was 4.10% per year.

Competitive Comparison of Shenzhen Weiguang Biological Products Co's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Shenzhen Weiguang Biological Products Co's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shenzhen Weiguang Biological Products Co's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shenzhen Weiguang Biological Products Co's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Shenzhen Weiguang Biological Products Co's 5-Year EBITDA Growth Rate falls into.

Shenzhen Weiguang Biological Products Co 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Shenzhen Weiguang Biological Products Co (SZSE:002880) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Shenzhen Weiguang Biological Products Co 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Shenzhen Weiguang Biological Products Co's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Shenzhen Weiguang Biological Products Co (SZSE:002880) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Weiguang Biological Products Co Ltd (SZSE:002880) » Definitions » 5-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

Guangming Street, No. 3402, Guangqiao Avenue, Guangming New District, Guangdong Province, Guangming, CHN, 518107

Website

http://www.szwg.com

Shenzhen Weiguang Biological Products Co Ltd is the pharmaceutical company. It is mainly engaged in the research and development, production and sales of blood products. The company's products portfolio includes human albumin, intravenous immunoglobulin (pH4), lyophilized human immunoglobulin (pH4), human immunoglobulin, hepatitis B human immunoglobulin, rabies immunoglobulin, tetanus Human immunoglobulin, histamine human immunoglobulin, human fibrinogen, a total of 21 varieties of 21 specifications.

Shenzhen Weiguang Biological Products Co (SZSE:002880) Headlines

No Headlines